BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 10754428)

  • 1. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
    Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
    Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
    Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
    Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
    Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone.
    Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Semler B; Decker K; Parapatics S; Tschida U; Winkler A; Saletu B
    Neuropsychobiology; 2001; 44(3):139-49. PubMed ID: 11586054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam.
    Saletu A; Parapatics S; Saletu B; Anderer P; Prause W; Putz H; Adelbauer J; Saletu-Zyhlarz GM
    Neuropsychobiology; 2005; 51(4):214-25. PubMed ID: 15915004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.
    Saletu B; Gruber G; Saletu M; Brandstätter N; Hauer C; Prause W; Ritter K; Saletu-Zyhlarz G
    Neuropsychobiology; 2000; 41(4):181-9. PubMed ID: 10828727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone.
    Saletu-Zyhlarz G; Anderer P; Gruber G; Mandl M; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Abu-Bakr MH; Grätzhofer E; Saletu B
    J Sleep Res; 2003 Sep; 12(3):239-54. PubMed ID: 12941063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.
    Saletu B; Kindshofer G; Anderer P; Grünberger J
    Int J Clin Pharmacol Res; 1987; 7(5):407-18. PubMed ID: 2889679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping.
    Saletu-Zyhlarz G; Saletu B; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):117-29. PubMed ID: 9313244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonorganic insomnia in panic Disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam.
    Saletu-Zyhlarz GM; Anderer P; Berger P; Gruber G; Oberndorfer S; Saletu B
    Hum Psychopharmacol; 2000 Jun; 15(4):241-254. PubMed ID: 12404319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
    Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
    J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
    Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia.
    Bettica P; Squassante L; Groeger JA; Gennery B; Winsky-Sommerer R; Dijk DJ
    Neuropsychopharmacology; 2012 Apr; 37(5):1224-33. PubMed ID: 22237311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ
    Int J Clin Pharmacol Res; 1989; 9(3):183-95. PubMed ID: 2568348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
    Roth T; Steinberg F; Singh NN; Moline M
    Hum Psychopharmacol; 2014 Jan; 29(1):25-30. PubMed ID: 24424704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls under placebo and acute treatment with zolpidem.
    Terzano MG; Parrino L
    Sleep; 1992 Feb; 15(1):64-70. PubMed ID: 1557595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.